Renewed Potential: Reviving an ALS Drug...Dr. Ari Azhir, Founder & CEO, Neuvivo

episode

BioTech Nation ... with Dr. Moira Gunn not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Hog Heaven, MAGA Hell 52 min · 24 Sep 2026 · I've Had It

KFC and Gen Z, OAPs and ChatGPT & An Email to Jimmy Fallon. 34 min · 24 Sep 2026 · Ray D'Arcy Daily

Bonds, Stocks Drop as Yields Extend Rally 2 min · 24 Sep 2026 · WSJ Minute Briefing

Judge gives press a pass 4 min · 24 Sep 2026 · Wall Street Breakfast

Court Temporarily Blocks Media Ban, Trump-Xi White House Meeting, UNGA Diplomacy 15 min · 24 Sep 2026 · Up First from NPR

6AM ET 09/24/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded17 Dec 2025

Publisherfeeds.transistor.fm ↗

Handlerec:14735905

Show notes

This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights and groundbreaking survival results, Neuvivo is giving hope to ALS patients and exploring its potential for other neurodegenerative diseases like Huntington’s and Alzheimer’s.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in